I think it was just to clear up timing on COVID Test as there has been plenty of conjecture on these threads. We will be using Doherty results on VTM based nasal swabs to get TGA approval in the next couple of weeks, allowing us to launch end of Q1 as promised ( we are NOT waiting for saliva results out of India ) We will be conducting Indian tests in Q2, and version B of our test will be launched with improved results ( we think ). SP drop probably because saliva based accreditation still a few months away, but this overlooks the high sales that will follow on from high sensitivity, LLOD +CT30 nasal swab test in a few weeks time !!
A buying opportunity for plenty here.
ADO Price at posting:
22.0¢ Sentiment: Buy Disclosure: Held
